Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.60 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.60 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.60 |
| ▸ | PGR | P06401 | 1/20 | 0.60 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.60 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.60 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.60 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.60 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.60 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.60 |
| ▸ | HTR2B | P41595 | 1/20 | 0.60 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.60 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.60 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | FPR2 | P25090 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SDCBP | O00560 | 1/20 | 0.38 |
| ▸ | SDC2 | P34741 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13907805 | 0.89 | CYP3A4 (0.59) | CYP3A4ABCC3ABCC4ABCB11PGR | |
| SCHEMBL13915801 | 0.89 | CYP3A4 (0.59) | CYP3A4ABCC3ABCC4ABCB11PGR | |
| SCHEMBL4175252 | 0.85 | ABCC3 (0.55) | CYP3A4ABCC3ABCC4ABCB11PGR | |
| SCHEMBL13915883 | 0.84 | ABCC3 (0.54) | CYP3A4ABCC3ABCC4ABCB11PGR | |
| SCHEMBL9943725 | 0.84 | CYP3A4 (0.77) | CYP3A4ABCC3ABCC4ABCB11PGR | |
| SCHEMBL4245489 | 0.84 | CYP3A4 (0.77) | CYP3A4ABCC3ABCC4ABCB11PGR | |
| SCHEMBL9943595 | 0.84 | CYP3A4 (0.77) | CYP3A4ABCC3ABCC4ABCB11PGR | |
| SCHEMBL13907784 | 0.83 | ABCC3 (0.53) | CYP3A4ABCC3ABCC4ABCB11PGR | |
| SCHEMBL9943748 | 0.83 | CYP3A4 (0.64) | CYP3A4ABCC3ABCC4ABCB11PGR | |
| SCHEMBL9943746 | 0.83 | CYP3A4 (0.64) | CYP3A4ABCC3ABCC4ABCB11PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090068719-A1 | IMMUNOASSAYS, HAPTENS, IMMUNOGENS AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS | VALDEZ JOHNNY | 2009-03-12 | — | — | US | disclosed |
| US-20090068719-A1 | IMMUNOASSAYS, HAPTENS, IMMUNOGENS AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS | VALDEZ JOHNNY | 2009-03-12 | — | — | US | disclosed |
| US-20090068719-A1 | IMMUNOASSAYS, HAPTENS, IMMUNOGENS AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS | VALDEZ JOHNNY | 2009-03-12 | — | — | US | disclosed |
| EP-1700122-A4 | IMMUNOASSAYS, HAPTENS, IMMUNOGENS AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS | ARK DIAGNOSTICS INC (US) | 2008-05-21 | — | — | EP | disclosed |
| EP-1700122-A2 | IMMUNOASSAYS, HAPTENS, IMMUNOGENS AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS | ARK DIAGNOSTICS (US) | 2006-09-13 | — | — | EP | disclosed |
| US-20050244816-A1 | Immunoassays, haptens, immunogens and antibodies for anti-HIV therapeutics | ARK DIAGNOSTICS, INC. (US) | 2005-11-03 | — | — | US | disclosed |
| WO-2005062979-A2 | IMMUNOASSAYS, HAPTENS, IMMUNOGENS AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS | ARK DIAGNOSTICS (US) | 2005-07-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090068719-A1 | IMMUNOASSAYS, HAPTENS, IMMUNOGENS AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS | CD4, MPI, ME1 | CYP3A4 70/4885ABCC3 1265/4885ABCC4 1132/4885 |
| US-20050244816-A1 | Immunoassays, haptens, immunogens and antibodies for anti-HIV therapeutics | CD4, MPI, ME1 | CYP3A4 70/4885ABCC3 1265/4885ABCC4 1132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.